An evaulation of fdg-pet in the detection and differentiation of thyroid tumours

Nuclear Medicine Communications

Volumn 18, Issue 10, 1997, Pages 957-963

  Sasaki, M ^a   Ichiya, Y ^a   Kuwabara, Y ^a   Akashi, Y ^a   Yoshida, T ^a   Fukumura, T ^a   Masuda, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SCHOOL CHILD; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROID TUMOR;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RECURRENCE; REFERENCE VALUES; THYROID HORMONES; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030682232     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199710000-00011     Document Type: Article

References (18)

1. Mazzaferri, EL. Management of a solitary thyroid nodule. N LnI I Mcii 1993; 328: 553-559.
2. lsF]fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest liuti iol 1986; 22: 360-371.
3. Nolop KB, Rhodes CC, Brudin LH et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682-2689.
4. Okada J, Yoshikawa K, Imaseki K et al. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis. J Nitcl Met! 1991; 32: 686-691.
5. Adler LP, Bloom AD. Positron emission tomography of thyroid masses. Thyroid 1993; 3: 195-200.
6. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 1993; 114: 728-735.
7. Sisson JC, Ackermann RJ, Meyer MA, Wahl RL. Uptake of 18-fluoro-2-deoxy-n-glucose by thyroid cancer: Implications for diagnosis and therapy. J Clin Endocrinol Mctnh 1993; 77: 1090-1094.
8. Scott GC, Meier DA, Dickinson CZ. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide. J Nucl Mai 1995; 36: 1843-1845.
9. Grünwald F, Schomburg A, Bender H et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Ear J Nucl Med 1996; 23: 312-319.
10. Feine U, Lietenmayer K, Hanke JP, Meld J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996; 37: 1468-1472.
11. 131l in patients with metastatic thyroid carcinoma. Nucl Med Coinmun 1997; 18: 3-9.
12. Kanno I, Miura S, Yamamoto S et al. Design and evaluation of a positron emission tomogram: HEADTOME 111. J Coin-put Assist Toinogr 1985; 9: 931-939.
13. Hatanaka M. Transport of sugars in tumor cell membrane. Biochnn Biophys Ac to 1974; 355: 77-104.
14. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
15. 99GaGe transmission scan in PET study (in Japanese)-Ipu I Nucl Med 1994; 31: 1511-1517.
16. Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Masuda K. High Jfluorodeoxyglucose uptake in abdominal abscess: A PET study. J Coinput Assist Toinogr 1989; 13: 829-831.
17. 81F)FDC. in brain abscess: A PET study. J Com put Assist Toinotfr 1990; 14: 486-487.
18. Ichiya Y, Kuwabara Y, Sasaki M et al. FDG-PFT in infectious lesions: The detection and assessment of lesion activity. Ann Nucl Med 1996; 10: 185-191.